RNAZ vs. BKNG

In the year-to-date period, RNAZ achieves a -92.80% return, which is significantly lower than BKNG's 11.31% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Transcode Therapeutics Inc (RNAZ) and Booking Holdings Inc. (BKNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RNAZ Sharpe Ratio is -0.47, which is lower than the BKNG Sharpe Ratio of 1.66. The chart below compares the historical Sharpe Ratios of RNAZ and BKNG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RNAZ has not paid dividends to shareholders, while BKNG's dividend yield for the trailing twelve months is around 0.65%.

The maximum RNAZ drawdown since its inception was -100.00%, roughly equal to the maximum BKNG drawdown of -99.32%. Use the drawdown chart below to compare losses from any high point for RNAZ and BKNG.

Transcode Therapeutics Inc (RNAZ) has a higher volatility of 55.77% compared to Booking Holdings Inc. (BKNG) at 5.13%. This indicates that RNAZ's price experiences larger fluctuations and is considered to be riskier than BKNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Transcode Therapeutics Inc and Booking Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.